General Information of the Compound
Compound ID
CP0256088
Compound Name
N-[(7-ethyl-3,4-dihydro-2H-chromen-2-yl)methyl]-N'-(1,4,5,6-tetrahydropyrimidin-2-yl)propane-1,3-diamine
    Show/Hide
Structure
Formula
C19H30N4O
Molecular Weight
330.476
Canonical SMILES
CCc1ccc2CCC(CNCCCNC3=NCCCN3)Oc2c1
    Show/Hide
InChI
InChI=1S/C19H30N4O/c1-2-15-5-6-16-7-8-17(24-18(16)13-15)14-20-9-3-10-21-19-22-11-4-12-23-19/h5-6,13,17,20H,2-4,7-12,14H2,1H3,(H2,21,22,23)
    Show/Hide
InChIKey
LLCUWOGFLPVSHF-UHFFFAOYSA-N
Physicochemical Property
logP
1.8612
Rotatable Bonds
7
Heavy Atom Count
24
Polar Areas
57.68
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
5
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44213966
ChEMBL ID
CHEMBL89878
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000803 HA7 Homo sapiens (Human)  1
1
IC50 = 3.981 nM
   TI
   LI
   LO
   TS